Immune modulating peptides for the treatment and suppression of multiple sclerosis: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    13 August 2022

    • curprev 12:4212:42, 13 August 2022‎ 187.21.138.9 talk‎ 562 bytes +562‎ Created page with "== Target Article == Immune modulating peptides for the treatment and suppression of multiple sclerosis; AH Badawi, TJ Siahaan; 2012; doi_citing_unknown == Retraction == Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis ; Vipin Kumar James L Urban Suzanna J Horvath Leroy Hood; 02/15/1990 ; https:..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Immune_modulating_peptides_for_the_treatment_and_suppression_of_multiple_sclerosis"